📢Glass ceiling are meant to be broken for paradigm-shift advancement
DB04 did it👏👏
HER2 “addiction” is not mandatory anymore for targeting successfully target HER2❗️
HER2low is only a pragmatic (and imperfect) way for patient selection (DAISY trial)
@ASCO
#BCSM